Irisin quartilesǂ | PSD, N | Unadjusted OR (95% CI)ξ | Adjusted OR (95% CI)*ξ |
|---|
Q1, N = 301 | 150 | 9.01 (5.80–13.98) | 4.85 (3.30–7.92) |
Q2, N = 301 | 110 | 4.96 (3.19–7.73) | 2.79 (1.82–4.37) |
Q3, N = 301 | 80 | 3.28 (2.08–5.18) | 1.82 (1.13–2.92) |
Q4, N = 302 | 30 | References | References |
- OR odds ratio, CI confidence interval, PSD post-stroke depression, NIHSS National Institutes of Health Stroke Scale, mRS Modified Rankin Scale, Hs-CRP high-sensitivity C-reactive protein, HCY homocysteine, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglyceride, TC total cholesterol, HOMA-IR homeostatic model of assessment insulin resistance, IL-6 interleukin-6
- ǂSerum levels of irisin in quartile 1 (< 71.1 ng/mL), quartile 2 (71.1–95.9 ng/mL), quartile 3 (96.0–144.0 ng/mL), and quartile 4 (> 144.0 ng/mL)
- *Adjusted for age, sex, BMI, stroke etiology, the NIHSS score, infarct volume, pre-stroke and acute treatment, vascular risk factors, mRS at follow-up, family history of psychiatric disorders, lesion location, living with offspring, widowhood, HOMA-IR, blood levels of glucose, Hs-CRP, HCY, IL-6, TG, TC, HDL, LDL, and serotonin and irisin quartiles
- ξP value for the trend < 0.001
